RxDoctor Payments Data

Cara Brown, APRN

Family · Moline, ILNPI 1003401498

Payments from drug & device makers

$4,776in general payments, 2019–2025

Across 89 payments — averaging $53.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$4K
  • Impulse Dynamics (USA) Inc.$260
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$228
  • Cvrx, Inc.$128
  • AstraZeneca$110
  • Masimo Corporation$81
  • plus $257 from 7 others

What the payments were for

  • Travel & lodging$2,59654%
  • Food & beverage$2,18046%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,776 in reported general payments places this provider in the 90th percentile of 4,941 family providers in Illinois.

See all family providers in Illinois

Medicare billing

Part B allowed, 2024
$22,049
Medicare patients
211
Services billed
282

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban175$216,040
EntrestoSacubitril/Valsartan38$60,126
XareltoRivaroxaban28$39,896
JardianceEmpagliflozin16$17,724
Metoprolol Succinate461$9,718
Flecainide Acetate130$5,985
Mexiletine Hcl11$1,579
Amiodarone Hcl60$1,122
Digoxin34$703
Carvedilol91$536
Dilt-XrDiltiazem Hcl11$502
Diltiazem 24hr Er (Cd)Diltiazem Hcl19$474
Losartan Potassium58$465
Amlodipine Besylate80$442
Potassium Chloride42$432

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$69$216,040175 claims
NovartisEntresto$35$60,12638 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,941 family providers in Illinois.

Other family in Moline

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →